Healthcare -
Biotechnology - NASDAQ - US
$ 1.277
-5.41 %
$ 148 M
Market Cap
-14.19
P/E
CHRS - LONG-TERM DEBT
Long-term Debt CHRS - Coherus BioSciences, Inc.
479 M
LAST VALUE
7.33%
2 YEAR CAGR
35.95%
5 YEAR CAGR
0.00%
10 YEAR CAGR